Al-Rawashde, F.A.; Al-Sanabra, O.M.; Alqaraleh, M.; Jaradat, A.Q.; Al-Wajeeh, A.S.; Johan, M.F.; Wan Taib, W.R.; Ismail, I.; Al-Jamal, H.A.N.
Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway. Pharmaceuticals 2023, 16, 884.
https://doi.org/10.3390/ph16060884
AMA Style
Al-Rawashde FA, Al-Sanabra OM, Alqaraleh M, Jaradat AQ, Al-Wajeeh AS, Johan MF, Wan Taib WR, Ismail I, Al-Jamal HAN.
Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway. Pharmaceuticals. 2023; 16(6):884.
https://doi.org/10.3390/ph16060884
Chicago/Turabian Style
Al-Rawashde, Futoon Abedrabbu, Ola M. Al-Sanabra, Moath Alqaraleh, Ahmad Q. Jaradat, Abdullah Saleh Al-Wajeeh, Muhammad Farid Johan, Wan Rohani Wan Taib, Imilia Ismail, and Hamid Ali Nagi Al-Jamal.
2023. "Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway" Pharmaceuticals 16, no. 6: 884.
https://doi.org/10.3390/ph16060884
APA Style
Al-Rawashde, F. A., Al-Sanabra, O. M., Alqaraleh, M., Jaradat, A. Q., Al-Wajeeh, A. S., Johan, M. F., Wan Taib, W. R., Ismail, I., & Al-Jamal, H. A. N.
(2023). Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK/STAT Signaling Pathway. Pharmaceuticals, 16(6), 884.
https://doi.org/10.3390/ph16060884
